Lasofoxifene and Reduced Breast Cancer Risk in Postmenopausal Women
Links shared publicly online about this topic
Lasofoxifene reduces breast cancer risk in postmenopausal osteoporotic women
physorg.com — “Lasofoxifene statistically reduced the overall risk of breast cancer, as well as ER positive invasive breast cancer in postmenopausal women with low bone density, according to a study published online in The Journal of the National Cancer Institute.” View full resource at physorg.com
Most Recently Shared on November 4, 2010 at 9:53 pm By:
Lasofoxifene reduces breast cancer risk in postmenopausal osteoporotic women http://bit.ly/90St0o
Lasofoxifene Reduces Breast Cancer Risk in Postmenopausal Osteoporotic Women " J. Natl. Cancer Inst.
jnci.oxfordjournals.org — “Lasofoxifene Reduces Breast Cancer Risk in Postmenopausal Osteoporotic Women " J. Natl. Cancer Inst.” View full resource at jnci.oxfordjournals.org
Most Recently Shared on November 5, 2010 at 3:44 pm By:
J Nat'l Cancer Inst Medical Journal and Oncology
Study shows lasofoxifene reduces breast cancer risk in postmenopausal women. See press release. http://fb.me/x4zxFoL3
Aromasin Reduced Breast Cancer Risk in Postmenopausal Women
health.yahoo.net — “SATURDAY, June 4 (HealthDay News) -- The anti-estrogen drug Aromasin appears to cut the odds of breast cancer by 65 percent in high-risk postmenopausal women, new research has found.” View full resource at health.yahoo.net
Most Recently Shared on June 6, 2011 at 4:27 am By:
Jane Anderson Healthy Eating Advisor
Aromasin Reduced Breast Cancer Risk in Postmenopausal Women http://bit.ly/lRQuoZ
Aromasin Reduced Breast Cancer Risk in Postmenopausal Women
health.yahoo.net — “SATURDAY, June 4 (HealthDay News) -- The anti-estrogen drug Aromasin appears to cut the odds of breast cancer by 65 percent in high-risk postmenopausal women, new research has found.” View full resource at health.yahoo.net
Most Recently Shared on June 5, 2011 at 6:42 pm By:
Jennifer Ann Grisso Nurse and Active Health Library
Aromasin Reduced Breast Cancer Risk in Postmenopausal Women: SATURDAY, June 4 (HealthDay News) -- The anti-estro... http://bit.ly/mqZ2sM
Lasofoxifene Helps Reduce Risk Of Bone Fractures, Breast Cancer, Heart Disease And Stroke
medicalnewstoday.com — “Low doses of the medication lasofoxifene can reduce the risk of vertebral and non-vertebral fractures, ER-positive breast cancer, coronary heart disease and stroke in postmenopausal women with ost” View full resource at medicalnewstoday.com
Most Recently Shared on February 25, 2010 at 7:09 pm By:
MNT Women's Health Health News
Lasofoxifene Helps Reduce Risk Of Bone Fractures, Breast Cancer, Heart Disease And Stroke http://mnt.to/3y6R #womenshealth
Lasofoxifene Helps Reduce Risk of Bone Fractures, Breast Cancer, Heart Disease and Stroke
newswise.com — “Low doses of the medication lasofoxifene can reduce the risk of vertebral and non-vertebral fractures, ER-positive breast cancer, coronary heart disease and stroke in postmenopausal women with osteoporosis. That’s the finding of a new study in the latest issue of the New England Journal of Medicine.” View full resource at newswise.com
Most Recently Shared on February 25, 2010 at 8:08 am By:
Men For A Cause (TM) Health Organization
Lasofoxifene Helps Reduce Risk of Bone Fractures, Breast Cancer, Heart Disease and Stroke http://shar.es/m0W1m via @sharethis
Aromasin Reduced Breast Cancer Risk in Postmenopausal Women - MSN Health - Breast Cancer
health.msn.com — “But at least one cancer expert says more research is needed” View full resource at health.msn.com
Most Recently Shared on June 4, 2011 at 9:25 pm By:
Bruce McLucas, MD Doctor, ObGyn Physician, Surgeon, and Physician
Aromasin Reduced Breast Cancer Risk in Postmenopausal Women http://ow.ly/1d3lGD
Exercising vigorously could reduce breast cancer risk for postmenopausal African American women - latimes.com
latimes.com — “Exercising vigorously could reduce breast cancer risk for postmenopausal African American women” View full resource at latimes.com
Most Recently Shared on October 1, 2010 at 9:43 pm By:
LA Times Health News Health News
Vigorous exercise could reduce breast cancer risk for postmenopausal African American women http://lat.ms/bFlVdp
Aromasin Reduced Breast Cancer Risk in Postmenopausal Women - Drugs.com MedNews
drugs.com — “The anti-estrogen drug Aromasin appears to cut the odds of breast cancer by 65 percent in high-risk postmenopausal women, new research has found. And unlike oth” View full resource at drugs.com
Most Recently Shared on June 6, 2011 at 1:32 am By:
Aromasin Reduced Breast Cancer Risk in Postmenopausal Women - http://bit.ly/j8vbsn
Aromasin Reduced Breast Cancer Risk in Postmenopausal Women - Drugs.com MedNews
drugs.com — “The anti-estrogen drug Aromasin appears to cut the odds of breast cancer by 65 percent in high-risk postmenopausal women, new research has found. And unlike oth” View full resource at drugs.com
Most Recently Shared on June 4, 2011 at 7:05 pm By:
Drugs and Devices OW OW Health
Aromasin Reduced Breast Cancer Risk in Postmenopausal Women: SATURDAY, June 4 -- The anti-estrogen drug Ar... http://bit.ly/je4qVi #drug
Exemestane Significantly Reduces Risk of Invasive, Preinvasive Breast Cancers in Postmenopausal Women at High Risk - MPR
empr.com — “Exemestane, an aromatase inhibitor, can be considered a new option for primary prevention of breast cancer in postmenopausal women, results of a randomized, placebo-controlled trial reported upon during the American Society of Clinical Oncology’s 2011 Annual Meeting and published online in The New England Journal of Medicine have found.” View full resource at empr.com
Most Recently Shared on June 4, 2011 at 9:16 pm By:
MPR News: Exemestane Significantly Reduces Risk of Invasive, Preinvasive Breast Cancers in Postmenopausal Women ... http://bit.ly/kYXDmj
Exemestane Significantly Reduces Risk of Invasive, Preinvasive Breast Cancers in Postmenopausal Women at High Risk - ONA
oncologynurseadvisor.com — “Exemestane, an aromatase inhibitor, can be considered a new option for primary prevention of breast cancer in postmenopausal women, results of a randomized, placebo-controlled trial reported upon during the American Society of Clinical Oncology’s 2011 Annual Meeting and published online in The New England Journal of Medicine have found.” View full resource at oncologynurseadvisor.com
Most Recently Shared on June 4, 2011 at 8:44 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Exemestane Significantly Reduces Risk of Invasive, Preinvasive Breast Cancers in… http://goo.gl/fb/FCmUA
Exemestane Reduces Breast Density In High Risk Postmenopausal Women, Suggests Early Study Analysis
medicalnewstoday.com — “A drug that shows promise for preventing breast cancer in postmenopausal women with an increased risk of developing the disease, appears to reduce mammographic breast density in the same group of” View full resource at medicalnewstoday.com
Most Recently Shared on December 11, 2010 at 1:05 pm By:
Exemestane Reduces Breast Density In High Risk Postmenopausal Women, Suggests Early Study Analysis http://mnt.to/3NTx #breastcancer
Genomic signature in post-menopausal women may explain why pregnancy reduces breast cancer risk
sciencedaily.com — “Women who have children, particularly early in life, have a lower lifetime risk of breast cancer compared with women who do not. Now, researchers have identified a gene expression pattern in breast tissue that differs between post-menopausal women who had children and post-menopausal women who did not. The results will help scientists understand why pregnancy reduces breast cancer risk.” View full resource at sciencedaily.com
Most Recently Shared on April 5, 2011 at 1:38 pm By:
Genomic signature in post-menopausal women may explain why pregnancy reduces breast cancer risk http://bit.ly/hFn4hc
Genomic signature in post-menopausal women may explain why pregnancy reduces breast cancer risk
physorg.com — “Women who have children, particularly early in life, have a lower lifetime risk of breast cancer compared with women who do not. Now, Fox Chase Cancer Center researchers have identified a gene expression pattern in breast tissue that differs between post-menopausal women who had children and post-menopausal ...” View full resource at physorg.com
Most Recently Shared on April 5, 2011 at 1:46 pm By:
Genomic signature in post-menopausal women may explain why pregnancy reduces breast cancer risk http://bit.ly/eBqN0Z
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
FightCancer
Cancer news feed, formerly part of a blog. RSS suggestions welcome.
-
J Nat'l Cancer Inst
JNCI, an Oxford University Press journal, publishes peer-reviewed original research and is an internationally acclaimed source for cancer news and information.
-
Jane Anderson
Advertisement
